The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
medimmune | 3825 |
spirogen | 259 |
astrazeneca | 238 |
adc therapeutics | 232 |
medlmmune | 126 |
wyeth | 95 |
seattle genetics | 92 |
medimmune vaccines | 91 |
amplimmune | 71 |
genentech | 66 |
medimmune | 491 |
adc therapeutics | 93 |
astrazeneca | 23 |
amgen | 13 |
seattle genetics | 9 |
biowa | 9 |
spirogen | 5 |
cambridge antibody technology | 4 |
definiens | 3 |
medlmmune | 3 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
pyrrolobenzodiazepine-antibody conjugates | 168 | 2012 |
methods of reducing eosinophil levels | 58 | 2007 |
targeted binding agents against b7-h1 | 57 | 2009 |
rsv-specific binding molecules and means for producing them | 51 | 2007 |
human antibody molecules for il-13 | 47 | 2003 |
binding members for interleukin-4 receptor alpha (il-4ralpha) | 43 | 2007 |
binding member for gm-csf receptor | 42 | 2006 |
pyrrolobenzodiazepines and conjugates thereof | 41 | 2010 |
stabilized liquid anti-rsv antibody formulations | 38 | 2002 |
methods for cultivating cells, propagating and purifying viruses | 37 | 2008 |